Individualizing Diagnosis, Treatment and Management of Multiple Myeloma: Patient with Early Relapse

This is the second of four modules associated with this activity.

These certified CME interactive case presentations will review recent clinical trial and published data that will support the appropriate management and treatment decisions recommended by the expert faculty in multiple myeloma.

During these interactive case presentations Drs. Joseph Mikhael and Nina Shah will address scenarios focusing on a newly diagnosed patient, early relapse, late relapse and patient requiring maintenance therapy, will be presented and discussed. The activity will be supported by downloadable slides that have the key discussion/teaching points.

There are no fees for participating in and receiving CME credit for this online activity.

Click 'register now' to access this activity.

1. Identify updates in the diagnosis and prognostic classification of multiple myeloma to guide initial therapy decisions;
2. Appraise novel therapeutic approaches for the treatment of relapsed multiple myeloma;
3. Optimize therapy of diverse patients with relapsed/refractory multiple myeloma to improve outcomes and minimize adverse effect.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Practice Point Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Physician Assistants (AAPA), Nurse Practitioners (AANP), and Nurses (ANCC) can count ACCME activities certified for AMA PRA Category 1 Credit™ for professional credit reporting purposes. All healthcare professionals, other than physicians, should inquire with their respective certifying or licensing boards to confirm.

Disclosure / Conflict of Interest Policy

The University is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The University requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all relationships with ineligible companies within the last 24-months. All identified conflicts of interests are thoroughly vetted and mitigated according to the ACCME and University’s policy. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.

Staff Disclosures
The University of Cincinnati and Practice Point Communications and the peer/content reviewers for this activity have no relevant conflict of interest to report.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati nor Practice Point Communications, recommends the use of any agent outside of the labeled indications.

Disclaimer Statement
The opinions expressed during this educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati or Practice Point Communications. The information is presented for the purpose of advancing the attendees’ professional development.

Learner Assurance Statement
The University of Cincinnati is committed to mitigating all conflicts of interest issues that could arise as a result of prospective faculty members’ relationships with ineligible companies. The University of Cincinnati is committed to retaining only those speakers with financial interests that can be mitigated as they relate to the goals and educational integrity of the CME activity.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This educational activity is supported by an educational grant from Amgen and Sanofi Genzyme.